Germany Legalizes Recreational Cannabis, Boosting Canadian Companies' Prospects in €1.7 Billion Market

Germany legalized cannabis effective April 1, 2024, opening opportunities for Canadian companies Aurora, Canopy Growth, and Tilray in a market projected to expand to €1.7 billion by 2025.

Aurora and Tilray are positioned as frontrunners due to their existing strongholds and prominence in Germany's medical cannabis market.

Stocks of cannabis companies surged in response, with Tilray up 11.1% and Canopy Growth up 33.8%.

Curaleaf International and its German subsidiary Four20 Pharma are poised to leverage connections to source cannabis.

Village Farms International is emerging as a standout performer due to financial health, domestic sales growth, and potential for international expansion.